The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
When confidence outpaces competence in clinical research, the risks can be hidden…and costly for trial sponsors
When confidence outpaces competence in clinical research, the risks can be hidden…and costly for trial sponsors
Clinical trials aren’t just more complex. They’re harder to manage, more expensive to run, and increasingly exposed to delay and disruption. Sponsors willing to take a different path can deliver faster, higher-quality trials at a lower cost.
I was recently invited to deliver a keynote presentation on embracing change. The audience was more than a 100 healthcare improvement and clinical trial professionals who had each committed to participate in a year-long collaborative.
The formal Formal adoption of the E6(R3) guideline introduces a proportionate and more modern risk-based approach to quality management. Clinical trial leaders must implement more effective training programs that address increased trial complexity and ensure compliance with the enhanced quality requirements.
Trial sponsors don’t miss timelines because they’re careless. They miss them because they’re human. Behavioral science calls it the planning fallacy.
We talk a lot about processes and platforms in clinical trials. But in the end, success comes down to understanding and supporting the needs of the people conducting the trial.
Ready has powered more than 1,000,000 user sessions with clinical professionals from over 90 countries to become the preferred study training tool for over 80% of site personnel.